Researchers identify existing drug that can prevent Covid-19 replication in host cells


Content Team
Image Credit: shortpedia

Scientists have identified a preexisting drug, used to treat multiple diseases, including bipolar disorders and hearing loss, that could prevent Covid from replicating in host cells, findings may lead to a therapeutic solution against Covid-19. The study, published in the journal Science Advances, assessed the molecule main protease, Mpro, of the novel coronavirus which is a key enzyme that plays a central role in its life cycle.